Mitochondriopathy, blepharospasm, and treatment with botulinum toxin.
Müller-Vahl
K R
KR
Kolbe
H
H
Egensperger
R
R
Dengler
R
R
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001764:Blepharospasm / Q000150:complications* / Q000188:drug therapy*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D005260:Female; D007839:Functional Laterality; D006801:Humans; D008875:Middle Aged; D008931:Mitochondria, Muscle / Q000473:pathology / Q000648:ultrastructure; D017240:Mitochondrial Myopathies / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D018482:Muscle, Skeletal / Q000473:pathology* / Q000648:ultrastructure; D009460:Neurologic Examination
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins